DAVITA (DVA) Revenue — Quarter Ended Sep 30, 2025
Revenue increased sequentially and year over year. The improvement was supported by gains in both dialysis patient service revenues and other revenues.
Key takeaway
Quarter ended Sep 30, 2025 · FY2025 Q3
Revenue increased sequentially and year over year. The improvement was supported by gains in both dialysis patient service revenues and other revenues.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$3.4B
Revenue reported for this quarter.
Quarter-over-quarter
+1.2%
Change from the immediately preceding quarter.
Year-over-year
+4.8%
Change from the comparable year-ago quarter.
Trailing four quarters
$13.3B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2024 | $3.3B | +4.7% |
| Mar 31, 2025 | $3.2B | +5.0% |
| Jun 30, 2025 | $3.4B | +6.1% |
| Sep 30, 2025 | $3.4B | +4.8% |
Revenue performance
The quarter's revenue growth was modest compared to the prior quarter but more pronounced versus the same quarter a year ago.
Quarterly comparison
When compared to the immediately preceding quarter, revenue rose slightly. Relative to the same quarter one year earlier, the increase was larger.
What to watch
The pace of revenue growth from the prior quarter may warrant attention given the more significant year-over-year increase.